文献速递临床试验与 GCP真实世界研究与卫生经济

中医协同照护用于中轴型脊柱关节炎患者的实用随机对照试验方案

Traditional Chinese medicine (TCM) collaborative care for patients with axial spondyloarthritis (AcuSpA): protocol for a pragmatic randomized controlled trial.
PubMed 文献 · Trials · 2019-01-14

本研究为一项实用随机对照试验方案,计划纳入160例对非甾体抗炎药反应不足的中轴型脊柱关节炎患者,按1:1随机分配至常规风湿科照护或中医协同照护模式(TCMCMC)组。

要点

  • 针对NSAIDs反应不足的AxSpA患者,比较TCMCMC与常规风湿科照护的实用随机对照试验。
  • 主要终点为第6周脊柱疼痛,次要终点包括临床、生活质量及经济指标,随访52周。

核心结论

  • 该试验旨在评估TCMCMC对AxSpA患者在临床疗效、安全性和成本效果方面的证据。

研究设计与样本

  • 实用随机对照试验,计划招募160例诊断为AxSpA且对NSAIDs反应不足的患者。
  • 采用简单随机化按1:1分配至常规风湿科照护组或TCMCMC干预组。
  • 主要终点第6周脊柱疼痛,次要终点包括临床、生活质量及经济结局,随访至52周并记录不良事件。

关键数值与推荐

  • TCMCMC定义为标准中医病史采集与体格检查、针刺、中医非药物建议及与风湿科医生沟通,外加常规风湿科照护。
  • 主要终点为第6周脊柱疼痛。
  • 随访至52周,记录不良事件。

临床怎么用

  • 该方案尚处试验阶段,暂不能提供临床实践推荐;结果将补充TCMCMC在AxSpA中临床疗效、安全性和成本效果的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Axial spondyloarthritis (AxSpA) is a chronic disease which results in fatigue, pain, and reduced quality of life (QoL). Traditional Chinese medicine (TCM), especially acupuncture, has shown promise in managing pain. Although a TCM collaborative model of care (TCMCMC) has been studied in cancer, there are no randomized controlled trials investigating TCM in AxSpA. Therefore, we will conduct a pragmatic trial to determine the clinical effectiveness, safety, and cost-effectiveness of TCMCMC for patients with AxSpA. We define TCMCMC as standard TCM history taking and physical examination, acupuncture, and TCM non-pharmacological advice and communications with rheumatologists in addition to usual rheumatologic care. The purpose of this paper is to describe the rationale for and methodology of this trial. METHODS/DESIGN: This pragmatic randomized controlled trial will recruit 160 patients who are diagnosed with AxSpA and have inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs). Simple randomization to usual rheumatologic care or the intervention (TCMCMC) with a 1:1 allocation ratio will be used. Ten 30-min acupuncture sessions will be provided to patients assigned to the TCMCMC arm. All participants will continue to receive usual rheumatologic care. The primary endpoint - spinal pain - will be evaluated at week 6. Secondary endpoints include clinical, quality of life, and economic outcome measures. Patients will be followed up for up to 52 weeks, and adverse events will be documented. DISCUSSION: This trial may provide evidence regarding the clinical effectiveness, safety, and cost-effectiveness of a TCMCMC for patients with AxSpA. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03420404 . Registered on 14 February 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kwan YH, Fong W, Ang XL, et al. Traditional Chinese medicine (TCM) collaborative care for patients with axial spondyloarthritis (AcuSpA): protocol for a pragmatic randomized controlled trial. Trials. 2019. PMID: 30642381. doi:10.1186/s13063-018-3117-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。